Major thrombocytopenia after balloon-expandable transcatheter aortic valve replacement: Prognostic implications and comparison to surgical aortic valve replacement

Catheterization and Cardiovascular Interventions

Volumn 85, Issue 1, 2015, Pages 130-137

  Jilaihawi, Hasan ^a   Doctor, Niraj ^a   Chakravarty, Tarun ^a   Kashif, Mohammad ^a   Mirocha, James ^a   Cheng, Wen ^a   Lill, Michael ^a   Nakamura, Mamoo ^a   Gheorghiu, Mitch ^a   Makkar Md, Raj R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Aortic valve replacement; Outcomes; TAVI; TAVR; Thrombocytopenia

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HAPTOGLOBIN; WARFARIN;

ACUTE KIDNEY FAILURE; AGED; AORTA VALVE REPLACEMENT; ARTICLE; BALLOON EXPANDABLE TRANSCATHETER AORTIC VALVE IMPLANTATION; BLEEDING; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; HEMOLYSIS; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PERCUTANEOUS AORTIC VALVE; PREDICTOR VARIABLE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; RISK; SEX DIFFERENCE; SURGICAL AORTIC VALVE REPLACEMENT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TRANSCATHETER AORTIC VALVE IMPLANTATION; VERY ELDERLY; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; BLOOD; COMPARATIVE STUDY; DEVICES; FEMALE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; KAPLAN MEIER METHOD; MALE; MORTALITY; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSTHESIS; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; ODDS RATIO; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 84923179181     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25430     Document Type: Article

References (22)

1. Matthai WH Jr. Thrombocytopenia in cardiovascular patients: Diagnosis and management. Chest 2005;127:46S-52S.
2. Berkowitz SD, Sane DC, Sigmon KN et al. Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group. J Am Coll Cardiol 1998;32:31-319.
3. van Straten AH, Hamad MA, Berreklouw E, ter Woorst JF, Martens EJ, Tan ME. Thrombocytopenia after aortic valve replacement: Comparison between mechanical and biological valves. J Heart Valve Dis 2010;19:394-349.
4. Leon MB, Smith CR, Mack M et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2011;363:1597-1607.
5. Grube E, Schuler G, Buellesfeld L et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: Device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76.
6. Smith CR, Leon MB, Mack MJ et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-2198.
7. Stasi R. How to approach thrombocytopenia. ASH Education Program Book 2012;2012:191-197.
8. Leon MB, Piazza N, Nikolsky E et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: A consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011;57:253-269.
9. Bagur R, Webb JG, Nietlispach F et al. Acute kidney injury following transcatheter aortic valve implantation: Predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 2010;31:865-874.
10. Shelat SG, Tomaski A, Pollak ES. Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia. Clin Appl Thromb Hemost 2008;14:410-414.
11. McCabe JM, Huang PH, Riedl LA et al. Incidence and implications of idiopathic thrombocytopenia following transcatheter aortic valve replacement with the Edwards Sapien valves: A single center experience. Catheter Cardiovasc Interv 2013;83:633-641.
12. Hilker L, Wodny M, Ginesta M, Wollert HG, Eckel L. Differences in the recovery of platelet counts after biological aortic valve replacement. Interact Cardiovasc Thorac Surg 2009;8:70-73.
13. Piccardo A, Rusinaru D, Petitprez B et al. Thrombocytopenia after aortic valve replacement with freedom solo bioprosthesis: a propensity study. Ann Thorac Surg 2010;89:1425-1430.
14. Tarzia V, Bottio T, Buratto E, Spiezia L, Simioni P, Gerosa G. Freedom solo stentless aortic valve: Quantitative and qualitative assessment of thrombocytopenia. Ann Thorac Surg 2011;92:1935.
15. Albacker TB. Invited commentary. Ann Thorac Surg 2010;89:1430-1431.
16. Grubitzsch H, Linneweber J, Kossagk C, Sanli E, Beholz S, Konertz WF. Aortic valve replacement with new-generation stentless pericardial valves: short-term clinical and hemodynamic results. J Heart Valve Dis 2005;14:623-629.
17. Beholz S, Konertz WE. Avoiding early partial valve thrombosis of the Pericarbon Freedom stentless valve. J Heart Valve Dis 2007;16:91-92.
18. Selleslagh P, Hamerlijnck R, De Sutter J. A rare case of aortic bioprosthesis thrombosis. Acta Cardiol 2010;65:253-254.
19. Trepels T, Martens S, Doss M, Fichtlscherer S, Schachinger V. Images in cardiovascular medicine. Thrombotic restenosis after minimally invasive implantation of aortic valve stent. Circulation 2009;120:e23-e24.
20. Noble S, Asgar A, Cartier R, Virmani R, Bonan R. Anatomopathological analysis after CoreValve Revalving system implantation. EuroIntervention 2009;5:78-85.
21. Pradella P, Bonetto S, Turchetto S et al. Platelet production and destruction in liver cirrhosis. J Hepatol 2011;54:894-900.
22. Grube E, Laborde JC, Gerckens U et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg first-in-man study. Circulation 2006;114:1616-1624.